Diagnostics and research stocks with the fastest earnings growth
Earnings per share over the last twelve months against the twelve months before, for companies profitable in both. As of .
- Ranked
- 17
- of 74 diagnostics and research stocks we cover
- Median
- +12.5%
- Highest
- +100.8%
- CDNA
- Range
- −67.1% to +100.8%
median +12.5%
−67.1%+100.8%
| # | Company | EPS growth | PE | Revenue growth (TTM) | Market cap |
|---|---|---|---|---|---|
| 1 | CDNACareDx | +100.8% | 35.9× | +38.9% | $4.5B |
| 2 | LHLabcorp | +33.3% | 29.4× | +6.4% | $28.9B |
| 3 | MEDPMedpace | +26.8% | 38.0× | +24.7% | $18.1B |
| 4 | DHRDanaher | +26.0% | 37.9× | +5.5% | $162.6B |
| 5 | AAgilent Technologies | +19.2% | 34.5× | +8.6% | $49.6B |
| 6 | IDXXIDEXX Laboratories | +18.4% | 46.5× | +12.8% | $52.1B |
| 7 | DGXQuest Diagnostics | +18.3% | 24.9× | +9.1% | $27.5B |
| 8 | IQVIQVIA | +16.6% | 32.0× | +8.2% | $42.5B |
| 9 | MTDMettler-Toledo International | +12.5% | 38.4× | +6.9% | $34.2B |
| 10 | LNTHLantheus | +9.8% | 24.3× | +2.3% | $6.5B |
| 11 | TMOThermo Fisher Scientific | +9.5% | 36.7× | +8.3% | $256.9B |
| 12 | RVTYRevvity | −11.0% | 72.2× | +4.1% | $16.9B |
| 13 | BIOBio-Rad Laboratories | −29.7% | 44.4× | +1.4% | $9.8B |
| 14 | ILMNIllumina | −32.0% | 44.0× | +4.9% | $35.7B |
| 15 | ICCCImmucell | −57.9% | 132× | +8.5% | $95.9M |
| 16 | WATWaters | −63.8% | 118× | +52.5% | $46.4B |
| 17 | NRCNRC Health | −67.1% | 97.0× | −0.2% | $536.6M |
Not ranked: 48 with not a meaningful number, 4 with no profit to compare, 1 with a quarter missing, 1 with growth above 300% (a base too small to compare). 3 companies whose data behind this number has a caveat are left out until it is checked.
A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.
EPS growth for other groups
Other rankings of diagnostics and research stocks
- Diagnostics and research stocks with the lowest PE ratio
- Diagnostics and research stocks cheapest against their own PE history
- Diagnostics and research stocks with the lowest price to sales ratio
- Diagnostics and research stocks with the lowest EV/EBIT
- Diagnostics and research stocks with the highest free cash flow yield
- Diagnostics and research stocks with the fastest revenue growth
- Diagnostics and research stocks with the fastest expected revenue growth
- Diagnostics and research stocks with the highest profit margins